SCHEMBL31076112

SCHEMBL31076112

CC(C)(C)OC(=O)N1CC[C@@H](NCCOC2CC2)C1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 1/20 0.47
USP30 Q70CQ3 7/20 0.45
CYP2C9 P11712 1/20 0.42
HSD11B1 P28845 1/20 0.42
ALDH1A1 P00352 3/20 0.42
PARP1 P09874 1/20 0.42
MAPT P10636 2/20 0.41
NPC1 O15118 1/20 0.41
MAPK1 P28482 1/20 0.41
HTT P42858 1/20 0.41
RAB9A P51151 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
GPR119 Q8TDV5 2/20 0.40
HDAC4 P56524 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
HPGD P15428 1/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
BRD4 O60885 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19990923 0.87 USP30 (0.49) EPHX1USP30CYP2C9HSD11B1ALDH1A1
SCHEMBL13712553 0.87 USP30 (0.49) EPHX1USP30CYP2C9HSD11B1ALDH1A1
SCHEMBL25237250 0.85 EPHX1 (0.52) EPHX1USP30CYP2C9HSD11B1ALDH1A1
SCHEMBL18556969 0.85 EPHX1 (0.52) EPHX1USP30CYP2C9HSD11B1ALDH1A1
SCHEMBL13696753 0.85 EPHX1 (0.52) EPHX1USP30CYP2C9HSD11B1ALDH1A1
SCHEMBL23555643 0.84 EPHX1 (0.51) EPHX1USP30CYP2C9HSD11B1ALDH1A1
SCHEMBL31075790 0.84 EPHX1 (0.46) EPHX1USP30CYP2C9HSD11B1ALDH1A1
SCHEMBL31421132 0.83 EPHX1 (0.53) EPHX1USP30CYP2C9HSD11B1ALDH1A1
SCHEMBL24033437 0.82 EPHX1 (0.49) EPHX1USP30CYP2C9HSD11B1ALDH1A1
SCHEMBL30999407 0.82 EPHX1 (0.49) EPHX1USP30CYP2C9HSD11B1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4665458-A1 INHIBITING ALPHA V BETA8 INTEGRIN Morphic Therapeutic, Inc. (US) 2025-12-24 EP disclosed
WO-2024173572-A1 INHIBITING α vβ8 INTEGRIN MORPHIC THERAPEUTIC, INC. (US) 2024-08-22 WO disclosed